CA2433962A1 - Compositions antibacteriennes de clarithromycine et processus de preparation connexe - Google Patents

Compositions antibacteriennes de clarithromycine et processus de preparation connexe Download PDF

Info

Publication number
CA2433962A1
CA2433962A1 CA002433962A CA2433962A CA2433962A1 CA 2433962 A1 CA2433962 A1 CA 2433962A1 CA 002433962 A CA002433962 A CA 002433962A CA 2433962 A CA2433962 A CA 2433962A CA 2433962 A1 CA2433962 A1 CA 2433962A1
Authority
CA
Canada
Prior art keywords
composition
weight
clarithromycin
granular
extra
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002433962A
Other languages
English (en)
Other versions
CA2433962C (fr
Inventor
Azita Saleki-Gerhardt
Rick Rafeldt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4171189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2433962(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority to CA2433962A priority Critical patent/CA2433962C/fr
Publication of CA2433962A1 publication Critical patent/CA2433962A1/fr
Application granted granted Critical
Publication of CA2433962C publication Critical patent/CA2433962C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA2433962A 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe Expired - Lifetime CA2433962C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2433962A CA2433962C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002393614A CA2393614C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe
CA2433962A CA2433962C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002393614A Division CA2393614C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe

Publications (2)

Publication Number Publication Date
CA2433962A1 true CA2433962A1 (fr) 2002-10-28
CA2433962C CA2433962C (fr) 2012-10-30

Family

ID=4171189

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2433962A Expired - Lifetime CA2433962C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe
CA002393614A Expired - Lifetime CA2393614C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002393614A Expired - Lifetime CA2393614C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe

Country Status (1)

Country Link
CA (2) CA2433962C (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200500213A1 (ru) * 2002-07-16 2005-08-25 Рэнбакси Лабораториз Лимитед Диспергируемые таблетки для орального назначения
TR201010860A2 (tr) * 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Sefdinir formulasyonları için üretim yöntemi.
TR201009167A2 (tr) * 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Sefalosporin içeren farmasötik granüller.

Also Published As

Publication number Publication date
CA2393614A1 (fr) 2002-10-28
CA2393614C (fr) 2003-09-30
CA2433962C (fr) 2012-10-30

Similar Documents

Publication Publication Date Title
JP3180350B2 (ja) β―ラクタム系抗生物質含有錠剤およびその製造法
ES2197351T3 (es) Granulado para la preparacion de composiciones de rapida desintegracion y disolucion que contiene una elevada cantidad de farmaco.
US20060034917A1 (en) Coating of tablet cores
KR20010024184A (ko) 활성 성분으로 클로드로네이트, 부형제로 실리시파이드미세결정성 셀룰로즈를 함유하는 의약 제제
CA2182004C (fr) Comprimes enrobes de paracetamol et de domperidone
AU759517B2 (en) Compositions comprising cefuroxime axetil
JP5630902B2 (ja) ゾルピデム酒石酸塩含有口腔内崩壊錠の製造方法
KR100522239B1 (ko) 아세트아미노펜을 함유하는 제어방출성의 경구용 제제
WO2010071320A2 (fr) Composition à libération contrôlée pour produire une préparation à libération prolongée contenant de l'udénafil
CA2435714A1 (fr) Comprimes de fenofibrate
US20090155369A1 (en) Pharmaceutical composition containing levodopa, entacapone and carbidopa
AU2007255392B2 (en) Process for making multiparticulates using a roller compactor
CA2433962A1 (fr) Compositions antibacteriennes de clarithromycine et processus de preparation connexe
WO2018029262A1 (fr) Composition pharmaceutique solide comprenant du sofosbuvir amorphe.
JPH04159222A (ja) 経口投与用固形薬剤の製造方法
WO2020122244A1 (fr) Comprimé, et procédé de fabrication de celui-ci
EP2410994A1 (fr) Composition pharmaceutique contenant de la levodopa, de l'entacapone et de la carbidopa
JP2004010575A (ja) 溶解性を改善した医薬組成物
WO2005021000A1 (fr) Formes posologiques solides de gatifloxacine a administration par voie orale
KR20060008167A (ko) 다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정
KR100754239B1 (ko) 염산세티리진과 염산슈도에페드린을 함유하는 제어방출성의 경구용 제제 및 그의 제조방법
KR20200002486A (ko) 습식과립 조성물, 이를 함유하는 정제 및 정제의 제조 방법
KR20110105550A (ko) 에카베트 또는 그의 염을 함유하는 경구용 정제
KR100399524B1 (ko) 신규경구제약학상제형
RU2023132871A (ru) Составы в фиксированных дозах

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20220719

MKEX Expiry

Effective date: 20220719